Loading...
Institute of Biomedical Research Corp.
MRES•PNK
Healthcare
Biotechnology
$0.009
$-0.00(-6.50%)

Institute of Biomedical Research Corp. (MRES) Balance Sheet Analysis
Institute of Biomedical Research Corp. (MRES) manages its money wisely, with plenty of N/A and N/A to cover its bills. The company’s long-term debts are N/A, balanced by steady 2371.35%. Shareholders’ stake in the business has grown thanks to smart decisions. Overall, the numbers show a solid position, giving it room to invest, expand, or adapt. For investors, this paints a promising picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan